Initial Public Stock Offering

Esperion Therapeutics

Esperion Files For $70M IPO

The Plymouth-based cholesterol drug developer Esperion Therapeutics Inc. has filed for an initial public stock offering with the federal Securities and Exchange Commission. Esperion is seeking to raise up to $70 million.

WWJ Newsradio 950–05/15/2013

Follow

Get every new post delivered to your Inbox.

Join 2,062 other followers